Dan is a Leicester medical graduate with a background in cancer research, histopathology and oncology. His PhD in the field of tumour suppressor genes was awarded from Imperial College London and he holds an MSc in Oncology from the Institute of Cancer Research. He completed higher medical training in the UK in Pharmaceutical Medicine.
Dan was the Deputy Director of the UK Medicines and Healthcare Products Regulatory Agency (MHRA)’s Innovation Accelerator with special interests in rare diseases, early access, health innovation, drug repurposing and patient-reported outcomes and engagement. Dan is currently Director, Regulatory Policy & Early Access at the Association of the British Pharmaceutical Industry (ABPI).
He is the editor author of the Oxford Specialist Handbook of Pharmaceutical Medicine and on the editorial board of Expert Opinion on Orphan Drugs and Rare Disease and Orphan Drugs Journal.
